By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.

YEAR FOUNDED:

April 20, 2009

LEADERSHIP:

Founders: Patrick Mahaffy, and Erle Mast

CEO and Co-founder: Patrick Mahaffy

CMO (Medical): Lindsey Rolfe

JOBS:

Please click here for Clovis Oncology job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


PRODUCTS:

All Products


Key Statistics


Email: info@clovisoncology.com
Ownership: Public

Web Site: Clovis Oncology
Employees:
Symbol: CLVS
 









Company News
Clovis Oncology (CLVS) Announces Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock 6/22/2017 6:51:19 AM
Clovis Oncology (CLVS) Announces Upsizing And Pricing Of Public Offering Of Common Stock 6/21/2017 6:43:35 AM
Clovis Oncology (CLVS) Announces Proposed Offering Of Common Stock 6/20/2017 7:07:14 AM
Clovis Oncology (CLVS) Stock Soars as Ovarian Cancer Trial Dazzles 6/19/2017 5:48:20 AM
Sienna Biopharma Appoints Erle Mast, Former CFO And Co-Founder Of Clovis Oncology (CLVS) To Board Of Directors 6/14/2017 12:00:10 PM
Why Pfizer (PFE), AstraZeneca PLC (AZN) and Clovis Oncology (CLVS) Aren’t Interested in Tesaro (TSRO) 6/2/2017 6:28:05 AM
Clovis Oncology (CLVS) Announces First Quarter 2017 Operating Results 5/4/2017 7:06:14 AM
Myriad Genetics (MYGN) And Clovis Oncology (CLVS) Sign Agreement For Use Of FDA-Approved Bracanalysis Cdx® Test To Identify Patients With Germline BRCA Mutations For Rubraca (Rucaparib) Treatment 4/27/2017 8:18:40 AM
Clovis Oncology (CLVS) To Announce First Quarter 2017 Financial Results And Host Webcast Conference Call On May 3 4/20/2017 10:37:54 AM
Clovis Oncology (CLVS) Announces Data Presentations At AACR Annual Meeting 2017 3/29/2017 7:07:57 AM
12345678910...
//-->